RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Clinical trial NCT06732492 · RECRUITING

Trial details

NCT number: NCT06732492
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

NK T-Cell Lymphoma CART Therapy CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies

Start date: 2024-10-31
Primary completion: 2026-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.